EUCTR2009-012141-34-GB进行中（未招募）不适用
Randomised Controlled Trial of the Use of Topical Application of Tranexamic Acid in Primary Total Hip Replacement. - (TRANX-H)
niversity Hospital of North Tees and Hartlepool0 个研究点目标入组 150 人开始时间: 2009年5月15日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Undergoing unilateral primary total hip replacement.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Undergoing unilateral primary total hip replacement for tumour.
- •2.Allergic to Tranexamic acid.
- •3.Bleeding tendency (e.g. Haemophilic and platelets disorders).
- •4.Warfarin, treatment dose of LMWH or conventional heparin).
- •5.History of DVT and pulmonary embolism.
- •6.Renal failure with creatinine > 250 micromole/l.
- •7.Female subjects of child bearing potential must have a negative pregnancy test.
研究者
相似试验
进行中（未招募）
不适用
Randomised Controlled Trial of the Use of Topical Application of Tranexamic Acid in Primary Cemented Total Knee Replacement (TRANX-K). - TRANX-KIn this study Tranexamic acid efficacy in reducing blood loss will be investigated in total knee replacement.Tranexamic acid will be applied topically to the exposed tissue around the knee joint prior to the wound closure and tourniquet release. It is anticipated that this method of administration will be quicker, easier and have less systemic side effect.MedDRA version: 9.1Level: LLTClassification code 10023227Term: Joint replacementEUCTR2007-007813-35-GBniversity Hospital of North Tees and Hartlepool
已完成
不适用
A randomised controlled trial to evaluate topical 10% metronidazole ointment for the treatment of perianal Crohn's diseaseDigestive SystemCrohn's disease [regional enteritis]Crohn's diseaseISRCTN54256247Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)30
尚未招募
不适用
Evaluation of four types of therapies for the treatment of urogenital atrophy in postmenopausal womeIn postmenopausal women with symptoms of urogenital atrophyN95.2RBR-2wjrp4Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM Unicamp
已完成
3 期
Randomized clinical trial of standardized topical formula containing standard extracts of Arnebia euchroma, Malva sylvestris and sesame oil (less than 20%) vs. Silversulfadiazine cream on wound healing in 2nd degree burnsprovides a standard herbal formulation to heal burn wounds.Burn and corrosion of trunk -Burn and corrosion of shoulder and upper limb -Burn and corrosion of wrist and hand -Burn and corrosion of hip and lower limb, except ankle and foot -Burn and corrosion of ankle and footT21,T22,T2IRCT201203059204N1Vice-Chancellor for Research, Shiraz University of Medical Sciences50
已完成
3 期
The impact of Althaea officinalis formulation on controlling the symptoms of atopic dermatitisAtopic Eczema.Other atopic dermatitisIRCT2016102323235N5Vice chancellor for research, Mashhad University of Medical Sciences40